Treatment of HIV-associated primary CNS lymphoma with antiretroviral therapy, rituximab, and high-dose methotrexate
Kathryn Lurain, Thomas S. Uldrick, Ramya Ramaswami, Mark N. Polizzotto, Priscila Gonçalves, Anaida Widell, Seth M. Steinberg, Elaine S. Jaffe, Stefania Pittaluga, Hao‐Wei Wang, Constance M. Yuan, Mary Anne Tamula, Staci Martin, Pamela L. Wolters, Jomy George, Richard F. Little, Robert Yarchoan
Topics & Concepts
RituximabMedicinePrimary central nervous system lymphomaMethotrexateLymphomaAntiretroviral therapyImmunologyHuman immunodeficiency virus (HIV)OncologyInternal medicineViral loadCNS Lymphoma Diagnosis and TreatmentLymphoma Diagnosis and TreatmentViral-associated cancers and disorders